Drontal Comp Forte vet. 525 mg/504 mg/175 mg Tablett
Drontal Comp Forte vet. 525 mg/504 mg/175 mg Tablett
Authorised
- Pyrantel embonate
- Praziquantel
- Febantel
Product identification
Medicine name:
Drontal Comp Forte vet. 525 mg/504 mg/175 mg Tablett
Active substance:
- Pyrantel embonate
- Praziquantel
- Febantel
Target species:
-
Dog
Route of administration:
-
In-feed use
-
Oral use
Product details
Active substance and strength:
-
Pyrantel embonate504.00/milligram(s)1.00Tablet
-
Praziquantel175.00/milligram(s)1.00Tablet
-
Febantel525.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AA51
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription except for some pack sizes
Authorisation status:
-
Valid
Authorised in:
-
Sweden
Available in:
-
Sweden
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Vetoquinol S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- KVP Pharma+Veterinaer Produkte GmbH
- Europeenne De Pharmacotechnie Europhartech
Responsible authority:
- Swedish Medical Products Agency
Authorisation number:
- 17307
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Swedish (PDF)
Published on: 19/06/2024
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Swedish (PDF)
Published on: 26/04/2022